Literature DB >> 28922565

"Metabolically Healthy" Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes: 5-year Japanese Cohort Study.

Masanari Kuwabara1,2,3, Remi Kuwabara4, Ichiro Hisatome5, Koichiro Niwa3, Carlos A Roncal-Jimenez1, Petter Bjornstad1,6, Ana Andres-Hernando1, Yuka Sato1, Thomas Jensen1, Gabriela Garcia1, Minoru Ohno2, James O Hill7, Miguel A Lanaspa1, Richard J Johnson1.   

Abstract

OBJECTIVE: Whether obesity without metabolic syndrome (i.e., "metabolically healthy" obesity) confers similar or less metabolic risk remains controversial.
METHODS: A retrospective 5-year cohort study of 9,721 Japanese subjects (48.5 ± 10.5 years, 4,160 men) was conducted in 2004 and reevaluated 5 years later. Subjects were excluded if they were hypertensive or diabetic or were receiving medications for dyslipidemia and/or gout or hyperuricemia in 2004. Study subjects were categorized according to baseline BMI  ≥ 25 kg/m2 (overweight/obesity) and < 25 kg/m2 (lean/normal weight) and also whether they had metabolic syndrome. The cumulative incidence of hypertension and diabetes over 5 years between groups was assessed. A second analysis evaluated whether baseline hyperuricemia provided additional risk.
RESULTS: Subjects with overweight/obesity but without metabolic syndrome carried increased cumulative incidence of hypertension (14.6% vs. 7.2%, P < 0.001) and diabetes (2.6% vs. 1.1%, P = 0.004) over 5 years compared to lean/normal subjects without metabolic syndrome. Overweight/obesity conferred an increased risk for diabetes even in individuals with normal fasting blood glucose. Hyperuricemia became an independent risk factor for developing hypertension over 5 years in lean/normal subjects without metabolic syndrome. A 1 mg/dL increase in serum uric acid carried increased risk for hypertension (19%) and diabetes (27%).
CONCLUSIONS: Metabolically healthy obesity and hyperuricemia confer increased risk for hypertension and diabetes.
© 2017 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28922565      PMCID: PMC5846469          DOI: 10.1002/oby.22000

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  38 in total

Review 1.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

Review 2.  The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome.

Authors:  Laurence S Sperling; Jeffrey I Mechanick; Ian J Neeland; Cynthia J Herrick; Jean-Pierre Després; Chiadi E Ndumele; Krishnaswami Vijayaraghavan; Yehuda Handelsman; Gary A Puckrein; Maria Rosario G Araneta; Quie K Blum; Karen K Collins; Stephen Cook; Nikhil V Dhurandhar; Dave L Dixon; Brent M Egan; Daphne P Ferdinand; Lawrence M Herman; Scott E Hessen; Terry A Jacobson; Russell R Pate; Robert E Ratner; Eliot A Brinton; Alan D Forker; Laura L Ritzenthaler; Scott M Grundy
Journal:  J Am Coll Cardiol       Date:  2015-09-01       Impact factor: 24.094

3.  A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population.

Authors:  Kazuo Hara; Yumi Matsushita; Momoko Horikoshi; Nobuo Yoshiike; Tetsuji Yokoyama; Heizo Tanaka; Takashi Kadowaki
Journal:  Diabetes Care       Date:  2006-05       Impact factor: 19.112

Review 4.  A systematic review of variables associated with the relationship between obesity and depression.

Authors:  K Preiss; L Brennan; D Clarke
Journal:  Obes Rev       Date:  2013-06-30       Impact factor: 9.213

Review 5.  Are there persons who are obese, but metabolically healthy?

Authors:  E A Sims
Journal:  Metabolism       Date:  2001-12       Impact factor: 8.694

6.  Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Koichiro Niwa; Ichiro Hisatome; Takahiko Nakagawa; Carlos A Roncal-Jimenez; Ana Andres-Hernando; Petter Bjornstad; Thomas Jensen; Yuka Sato; Tamara Milagres; Gabriela Garcia; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson
Journal:  Hypertension       Date:  2017-04-10       Impact factor: 10.190

7.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

Authors:  Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers
Journal:  Arch Intern Med       Date:  2008-08-11

8.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

Review 9.  Beyond BMI: The "Metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic review.

Authors:  Lara L Roberson; Ehimen C Aneni; Wasim Maziak; Arthur Agatston; Theodore Feldman; Maribeth Rouseff; Thinh Tran; Michael J Blaha; Raul D Santos; Andrei Sposito; Mouaz H Al-Mallah; Ron Blankstein; Matthew J Budoff; Khurram Nasir
Journal:  BMC Public Health       Date:  2014-01-08       Impact factor: 3.295

10.  Increased Serum Sodium and Serum Osmolarity Are Independent Risk Factors for Developing Chronic Kidney Disease; 5 Year Cohort Study.

Authors:  Masanari Kuwabara; Ichiro Hisatome; Carlos A Roncal-Jimenez; Koichiro Niwa; Ana Andres-Hernando; Thomas Jensen; Petter Bjornstad; Tamara Milagres; Christina Cicerchi; Zhilin Song; Gabriela Garcia; Laura G Sánchez-Lozada; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

View more
  15 in total

1.  Risk of hypertension among different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Atieh Mirzababaei; Hadis Mozaffari; Sakineh Shab-Bidar; Alireza Milajerdi; Kurosh Djafarian
Journal:  J Hum Hypertens       Date:  2018-12-19       Impact factor: 3.012

2.  Early onset of hyperuricemia is associated with increased cardiovascular disease and mortality risk.

Authors:  Lijun Li; Maoxiang Zhao; Chi Wang; Sijin Zhang; Cuijuan Yun; Si Chen; Liufu Cui; Shouling Wu; Hao Xue
Journal:  Clin Res Cardiol       Date:  2021-04-12       Impact factor: 5.460

3.  High Level of Uric Acid Promotes Atherosclerosis by Targeting NRF2-Mediated Autophagy Dysfunction and Ferroptosis.

Authors:  Wei Yu; Weidong Liu; Qiang Wang; Chenxi Xu; Hairong Zhao; Jiaming Lv; Furong He; Bingyang Chen; Tetsuya Yamamoto; Hidenori Koyama; Jidong Cheng
Journal:  Oxid Med Cell Longev       Date:  2022-04-18       Impact factor: 7.310

4.  Hyperosmolarity and Increased Serum Sodium Concentration Are Risks for Developing Hypertension Regardless of Salt Intake: A Five-Year Cohort Study in Japan.

Authors:  Masanari Kuwabara; Mehmet Kanbay; Koichiro Niwa; Ryusuke Ae; Ana Andres-Hernando; Carlos A Roncal-Jimenez; Gabriela Garcia; Laura Gabriela Sánchez-Lozada; Bernardo Rodriguez-Iturbe; Ichiro Hisatome; Miguel A Lanaspa; Richard J Johnson
Journal:  Nutrients       Date:  2020-05-14       Impact factor: 5.717

5.  Metabolic Unhealthiness Increases the Likelihood of Having Metabolic Syndrome Components in Normoweight Young Adults.

Authors:  Bagas Suryo Bintoro; Yen-Chun Fan; Chia-Chi Chou; Kuo-Liong Chien; Chyi-Huey Bai
Journal:  Int J Environ Res Public Health       Date:  2019-09-05       Impact factor: 3.390

6.  Cross-sectional study of associations between normal body weight with central obesity and hyperuricemia in Japan.

Authors:  Takako Shirasawa; Hirotaka Ochiai; Takahiko Yoshimoto; Satsue Nagahama; Akihiro Watanabe; Reika Yoshida; Akatsuki Kokaze
Journal:  BMC Endocr Disord       Date:  2020-01-06       Impact factor: 2.763

7.  Nonlinear relationship between serum uric acid and body mass index: a cross-sectional study of a general population in coastal China.

Authors:  Hui Zhou; Zhen Liu; Zhong Chao; Yeqing Chao; Lidan Ma; Xiaoyu Cheng; Yangang Wang; Changgui Li; Ying Chen
Journal:  J Transl Med       Date:  2019-11-25       Impact factor: 5.531

8.  The visceral fat area to leg muscle mass ratio is significantly associated with the risk of hyperuricemia among women: a cross-sectional study.

Authors:  Xiao-He Wang; Wei-Ran Jiang; Min-Ying Zhang; Ying-Xin Shi; Yun-Ping Ji; Chun-Jun Li; Jing-Na Lin
Journal:  Biol Sex Differ       Date:  2021-01-29       Impact factor: 5.027

9.  Long-term impact of baseline serum uric acid levels on living kidney donors: a retrospective study.

Authors:  Kosuke Tanaka; Shigeyoshi Yamanaga; Yuji Hidaka; Sho Nishida; Kohei Kinoshita; Akari Kaba; Toshinori Ishizuka; Satoshi Hamanoue; Kenji Okumura; Chiaki Kawabata; Mariko Toyoda; Akira Miyata; Masayuki Kashima; Hiroshi Yokomizo
Journal:  BMC Nephrol       Date:  2021-03-12       Impact factor: 2.388

10.  The Optimal Range of Serum Uric Acid for Cardiometabolic Diseases: A 5-Year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Ichiro Hisatome; Koichiro Niwa; Petter Bjornstad; Carlos A Roncal-Jimenez; Ana Andres-Hernando; Mehmet Kanbay; Richard J Johnson; Miguel A Lanaspa
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.